How To Get Ahead In The Trendy World Of Immuno-Oncology
Executive Summary
With basic research in immuno-oncology still very limited, there are still a lot of opportunities to develop new breakthrough therapies beyond checkpoint inhibitors, companies active in the space said during a panel at the recent Biotech Showcase.